You are now leaving www.admabiologics.com
The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 06/14/21 | 8-K | Current report filing |
|
   |
1 |
| 06/03/21 | UPLOAD | SEC-generated letter |
|
1 | |
| 05/28/21 | 8-K | Current report filing |
|
|
18 |
| 05/28/21 | S-3 | Registration statement for specified transactions by certain issuers |
|
109 | |
| 05/28/21 | 8-K | Current report filing |
|
|
3 |
| 05/12/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
76 |
| 05/12/21 | 8-K | Current report filing |
|
|
6 |
| 04/28/21 | 8-K | Current report filing |
|
|
3 |
| 04/12/21 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | |
| 04/08/21 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 |
